首页> 外文期刊>RSC Advances >Core/shell upconversion nanoparticles with intense fluorescence for detecting doxorubicin in vivo
【24h】

Core/shell upconversion nanoparticles with intense fluorescence for detecting doxorubicin in vivo

机译:具有强荧光的核/壳上转换纳米颗粒,用于体内检测阿霉素

获取原文
获取外文期刊封面目录资料

摘要

Doxorubicin (Dox) is a chemotherapy medication used to treat cancer. Herein, we report a rapid and efficient method for detecting Dox in vivo based on a NaGdF _(4) :Yb ~(3+) ,Er ~(3+) @NaYF _(4) core/shell upconversion nanoparticles (UCNPs) probe. We found that the intensity ratio of green to red emission (IGVRE) bands of the core/shell NaGdF _(4) :Yb ~(3+) ,Er ~(3+) @NaYF _(4) nanoparticles was sensitive to Dox in blood samples, and drops as the concentration of Dox increases. In addition, the proposed UCNPs probe possessed the advantage that no nanoparticles leaked into the living body, thus overcoming the intrinsic defect (difficulty in removing UCNPs from blood vessels) of the fluorescence resonance energy transfer (FRET) approach. This proposed UCNP probe design and results may provide some guidance for the real-time and efficient detection of Dox, and can be helpful in biomedical applications.
机译:阿霉素(Dox)是用于治疗癌症的化学疗法药物。本文中,我们报告了一种基于NaGdF _(4):Yb〜(3+),Er〜(3+)@NaYF _(4)核/壳上转换纳米粒子(UCNPs)的快速有效的体内Dox检测方法。探测。我们发现,核/壳NaGdF _(4):Yb〜(3+),Er〜(3+)@NaYF _(4)纳米粒子的绿色与红色发射(IGVRE)谱带的强度比对Dox敏感。在血液样本中,并随着Dox浓度的增加而下降。另外,所提出的UCNPs探针具有以下优点:没有纳米颗粒泄漏到活体内,从而克服了荧光共振能量转移(FRET)方法的固有缺陷(难以从血管中去除UCNP)。提议的UCNP探针设计和结果可能为实时有效检测Dox提供一些指导,并且在生物医学应用中可能会有所帮助。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号